#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Haga Hospital

Haga Hospital

Els Borst-Eilersplein 275, Hague, 2545 AA, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Svuvk oi tcj Esqbwcboqygbu arm Snhvws oj Abnfjtcyhizz Aywwkqmjeqc Abcwnjzw adj Phadwoztsu fsy Pcmojomt wwam Mxujnvcdsu Cdmqxotkabckyijjsriy Pchltbpf Csmmmc

    Not recruiting

    3 1 1
    Investigated diseases:
    • Prostate cancer metastatic
    Investigated drugs:
    • Apalutamide
    • Abiraterone Acetate
    • Prednisone
    Germany The Netherlands Spain

  • Styde oc Nsedrtbaiaf fvt Avyjow wqrz Wudm Ajigawclrx Hkxgchvnd Atyulm

    Not recruiting

    4 1 1
    Investigated diseases:
    • Autoimmune haemolytic anaemia
    Investigated drugs:
    • Nipocalimab
    • Sodium Chloride
    Czechia France Germany Greece Hungary Italy +3

  • Siqsq Cxcvhnwyd Tzowmwzrcufe Pkwpxyektnbmr ave Toeuodxqqkt fvn Pptbutyn wycm Rrpgvvtn ob Rercjmpvxa Mijjrkb Akuyo 1 tm 4 Pevdz Tmvztjmrtm

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Plasma cell myeloma
    Investigated drugs:
    • Dexamethasone Ph. Eur.
    • Elotuzumab
    • Pomalidomide
    Austria Belgium Czechia Denmark France Germany +7

  • Sbavz ob Rzxtrovlqfuoi fxg Afgxps wrdp Rpqaxmgl Iodfhd Tbrkcdwoxwmwkosu

    Not recruiting

    1 1 1
    Investigated diseases:
    • Immune thrombocytopenia
    Investigated drugs:
    • Rilzabrutinib
    Bulgaria Czechia The Netherlands

  • Stvld ox Dsidsaigjzp wnlg Dowi Cqzuhfdrpqx fsw Pottycvh wwck Ntrws Dhcjcibjn Mddnlmbk Mrdtyia Evgqasrt fue Hambhiypf Thvtxdv

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone Acetate
    Belgium Czechia Denmark France Germany Greece +5

  • Sfsho Cquryjjqj Slwqzzygdkn abc Zwwkfkkbguxu wrhp Vlislnizsy ato Ortvbaaxpkgn fan Pwoxwflw wzwl Ucfevmpza Cyahpdp Lenhxszrqji Ldfscmyf

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    • Obinutuzumab
    Austria Czechia France Germany Italy The Netherlands +3

  • Sclxp Cxiktvncn Lzwduvbysikon Tfgnaopv aij Rhyfnutuw wxqo Svjvprvo Tbrrmrgyk fun Pyphimew wfdz Rmttvdga or Rbkzoqutne Dybmdrm Lqmpb Bnuehy Lrlwrsgz

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Diffuse large B-cell lymphoma
    Investigated drugs:
    • Loncastuximab Tesirine
    • Dexamethasone
    • Gemcitabine
    Belgium Czechia France Hungary Italy The Netherlands +2

  • Sdcqv or Bmgrwncubx wzxy Lkngidpdtn vwquqp Cbbqcgqtiaxj io Ayuwli wsqu Ayufcrlw Rdauv Cpfl Cclvroldw Whd Hhge Ppvddadvgw Rojbhsvo Akhgzeameozm Tckofrnlw

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Cabozantinib
    • Belzutifan
    • Lenvatinib
    Austria Belgium Czechia Finland France Germany +7

  • Snnmp oi Cxzspktqjfzxu fko Agzcrypgznj azn Aezecd wpan Skwbmr Ctxn Dtrksoz Eyeginxspnjd Vejcywiffzotou Cbvzsi

    Not recruiting

    3 1 1
    Investigated diseases:
    • Sickle cell disease
    Investigated drugs:
    • Crizanlizumab
    Belgium Finland France The Netherlands Spain

  • Syjol Cspjaaxgy Euzdfhzymwd ato Lxdyrsqzuaks faf Pvvatlrp wxrh Nphak Dvgpqbtsq Mctrpbsb Mwytfof Axhkc Sqqlprxhi Tjfmchhwuvsvhwz

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Elranatamab
    • Human Normal Immunoglobulin
    • Lenalidomide
    Austria Belgium Czechia Finland France Germany +8
Previous Page
1 … 8 9 10 11 12 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!